Mimedx (MDXG) Net Income (2011 - 2026)

Mimedx (MDXG) has 15 years of Net Income data on file, last reported at -$10.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income changed N/A year-over-year to -$10.9 million; the trailing twelve-month figure through Mar 2026 stood at -$10.9 million (down 5014.03% YoY), and the FY2024 full-year result was $421000.0, up 104.57% from the prior year.
• Net Income declined to -$10.9 million in Q1 2026, from $217000.0 in the prior quarter.
• In the past five years, Net Income ranged from a high of $9.8 million in Q4 2022 to a low of -$10.9 million in Q2 2022.
• A 4-year average of -$3.3 million and a median of -$1.7 million in 2023 frame the typical range for Net Income.
• Peak annual rise in Net Income reached 4839.7% in 2022, while the deepest fall reached 510.91% in 2022.
• Tracing MDXG's Net Income over 4 years: stood at $9.8 million in 2022, then plunged by 77.73% to $2.2 million in 2023, then sank by 90.09% to $217000.0 in 2024, then plunged by 5104.61% to -$10.9 million in 2026.
• Business Quant data shows MDXG's Net Income at -$10.9 million in Q1 2026, $217000.0 in Q3 2024, and $4000.0 in Q2 2024.